Patent Assignment
Reel/Frame 059390/0606
Change of Name
Recorded: 2022-03-17
Pages: 5
Assignor
GEMOAB GMBH
Executed: 2021-11-30
Assignee
AVENCELL EUROPE GMBH
TATZBERG 47, DRESDEN, 01307, GERMANY
Covered Properties
(5)
Universal Chimeric Antigen Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Universal Chimeric Antigen Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Application:
16/798,255 →
Publication:
US 2021/0206828
Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer Infections and Autoimmune Disorders
Reversed Universal Chimeric Antigen Receptor Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Application:
17/251,447 →
Publication:
US 2021/0309751
Universal Chimeric Antigen Expressing Immune Cells for Targeting of Diverse Multiple Antigens and Method of Manufacturing the Same and Use of the Same for Treatment of Cancer, Infections and Autoimmune Disorders
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 15, 2017
From: BACHMANN, MICHAEL; EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 043602/0138 →
Assignment of Assignor's Interest
Dec 3, 2019
From: EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 051163/0010 →
Assignment of Assignor's Interest
Feb 18, 2020
From: BACHMANN, MICHAEL; EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 051851/0079 →
Assignment of Assignor's Interest
Apr 19, 2020
From: BACHMANN, MICHAEL; EHNINGER, ARMIN
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 052436/0024 →
Assignment of Assignor's Interest
Dec 11, 2020
From: BACHMANN, MICHAEL
To: GEMOAB MONOCLONALS GMBH
Reel/Frame 054617/0820 →
Change of Name
Nov 23, 2021
From: GEMOAB MONOCLONALS GMBH
To: GEMOAB GMBH
Reel/Frame 058566/0170 →
Security Interest
Jan 4, 2024
From: AVENCELL THERAPEUTICS, INC.
To: BXLS V - DIAMANT L.P., AS COLLATERAL AGENT
Reel/Frame 066026/0610 →
Release of Security Interest
Oct 18, 2024
From: BXLS V – DIAMANT L.P.
To: AVENCELL THERAPEUTICS, INC.
Reel/Frame 068941/0187 →